Status:
COMPLETED
Gynecologic Cancer Lymphedema Questionnaire as a Clinical Care Tool to Identify Lower Extremity Lymphedema
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Ovarian Cancer
Uterine Cancer
Eligibility:
FEMALE
21+ years
Brief Summary
The purpose of this study is to evaluate if the Gynecologic Cancer Lymphedema Questionnaire (GCLQ) truly detects symptoms or signs of lower extremity lymphedema in patients with diagnosed lower extrem...
Eligibility Criteria
Inclusion
- Study group of Gynecologic cancer survivors with Lymphedema
- Documented lower extremity lymphedema
- History of a primary diagnosis of gynecologic cancer (vulvar, cervical and uterine only)
- History of surgery for gynecologic cancer including lymph node removal
- No evidence of disease or active treatment
- At least 21 years of age
- Able and willing to provide informed consent
- English fluency Comparison Group of Gynecologic Cancer Survivors without Lymphedema
- No history of lower extremity lymphedema or presence of lymphedema confirmed by limb volume measurements at the time of study participation
- History of a primary diagnosis of gynecologic cancer (vulvar, cervical and uterine only)
- History of surgery for gynecologic cancer including lymph node removal
- No evidence of disease or active treatment
- At least 21 years of age
- Able and willing to provide informed consent
- English fluency
Exclusion
- Inability to participate in an informed consent process
- Patients with a psychiatric disorder precluding response to the survey
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT00944944
Start Date
July 1 2009
End Date
January 1 2010
Last Update
February 1 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065